• Latest Posts

Welcome to the Blockbuster Club, Genmab!

Swedish Oncology Biotech makes a Large IPO for its Peptides

The 10 Biggest Clinical Success Stories of 2016 in European Biotech

How is European Immuno-Oncology fighting Blood Cancer?

Spain joins the Antibody-Drug Conjugate Bandwagon to fight Cancer

ADVERTISEMENT

Celyad’s Autologous CAR-T Therapy enters Phase Ib

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

Key German Hospital to start a Phase I trial in TCR Cell Therapy

Mystery Biotech No One has Ever Heard of in Biggest Deal of the Year for $7Bn

Best-in-Class Label for Blood Cancer Trial by Billion Euro Biotech

ADVERTISEMENT